H2 | Featured Articles |
H2 | Featured Investigation |
H2 | Explore |
H2 | How we work |
H2 | How we work Text-Duplikat |
H2 | We work with |
H3 | Cross-border stories from a changing Europe, in your inbox. |
H3 | Deadly prices |
H3 | Our themes |
H3 | Europe investigated. Journalism that goes beyond national borders. |
H4 | Infringement cold cases: member states left unpunished for dozens of EU law violations |
H4 | Infringement cold cases: member states left unpunished for dozens of EU law violations Text-Duplikat |
H4 | Infringement cold cases: member states left unpunished for dozens of EU law violations Text-Duplikat |
H4 | Infringement cold cases: member states left unpunished for dozens of EU law violations Text-Duplikat |
H4 | Drug firms finance Europe’s patient groups with multi-million donations |
H4 | Drug firms finance Europe’s patient groups with multi-million donations Text-Duplikat |
H4 | Big pharma influence hangs over Europe’s medicines regulator |
H4 | Big pharma influence hangs over Europe’s medicines regulator Text-Duplikat |
H4 | Cross-border stories from a changing Europe, in your inbox. Text-Duplikat |
H4 | Deadly prices Text-Duplikat |
H4 | Our themes Text-Duplikat |
H4 | Deadly prices: how big pharma feeds inequality in Europe |
H4 | Deadly prices: how big pharma feeds inequality in Europe Text-Duplikat |
H4 | Europe investigated. Journalism that goes beyond national borders. Text-Duplikat |
H4 | HELP US CONNECT THE DOTS ON EUROPE |
H4 | Investigations |
H4 | About |
H4 | More |
H5 | Drug firms finance Europe’s patient groups with multi-million donations Text-Duplikat |
H5 | Drug firms finance Europe’s patient groups with multi-million donations Text-Duplikat |
H5 | Big pharma influence hangs over Europe’s medicines regulator Text-Duplikat |
H5 | Big pharma influence hangs over Europe’s medicines regulator Text-Duplikat |
H5 | Deadly prices: European Commission rejects cancer drug removal over ‘impartiality’ concerns |
H5 | Deadly prices: European Commission rejects cancer drug removal over ‘impartiality’ concerns Text-Duplikat |
H5 | Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices |
H5 | Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices Text-Duplikat |
H5 | From transparency to public research: how to make medicines a right not just a business |
H5 | From transparency to public research: how to make medicines a right not just a business Text-Duplikat |
H5 | Alarming gaps in availability of innovative drugs across the EU |
H5 | Alarming gaps in availability of innovative drugs across the EU Text-Duplikat |
H5 | Cystic fibrosis ‘miracle’ drugs priced higher for poorer EU countries |
H5 | Cystic fibrosis ‘miracle’ drugs priced higher for poorer EU countries Text-Duplikat |
H5 | Hardline EU governments in late push to legitimise surveillance of journalists |
H5 | Hardline EU governments in late push to legitimise surveillance of journalists Text-Duplikat |
H5 | Deadly prices: European Commission rejects cancer drug removal over ‘impartiality’ concerns Text-Duplikat |
H5 | Deadly prices: European Commission rejects cancer drug removal over ‘impartiality’ concerns Text-Duplikat |
H5 | Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices Text-Duplikat |
H5 | Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices Text-Duplikat |
H5 | From transparency to public research: how to make medicines a right not just a business Text-Duplikat |
H5 | From transparency to public research: how to make medicines a right not just a business Text-Duplikat |
H5 | Alarming gaps in availability of innovative drugs across the EU Text-Duplikat |
H5 | Alarming gaps in availability of innovative drugs across the EU Text-Duplikat |
H5 | Cystic fibrosis ‘miracle’ drugs priced higher for poorer EU countries Text-Duplikat |
H5 | Cystic fibrosis ‘miracle’ drugs priced higher for poorer EU countries Text-Duplikat |
H5 | Hardline EU governments in late push to legitimise surveillance of journalists Text-Duplikat |
H5 | Hardline EU governments in late push to legitimise surveillance of journalists Text-Duplikat |
H5 | How big pharma feeds inequality in Europe |
H5 | Deadly prices: how big pharma feeds inequality in Europe Text-Duplikat |
H5 | Documentary: Investigação Europa - Geography of Discontent |
H5 | Documentary: Investigação Europa - Geography of Discontent Text-Duplikat |
H5 | Mining in my backyard: Europe’s new mines divide communities |
H5 | Mining in my backyard: Europe’s new mines divide communities Text-Duplikat |
H5 | Deadly prices: how big pharma feeds inequality in Europe Text-Duplikat |
H5 | Documentary: Investigação Europa - Geography of Discontent Text-Duplikat |
H5 | Documentary: Investigação Europa - Geography of Discontent Text-Duplikat |
H5 | Mining in my backyard: Europe’s new mines divide communities Text-Duplikat |
H5 | Mining in my backyard: Europe’s new mines divide communities Text-Duplikat |
H6 | Leere Überschrift |
H6 | Leere Überschrift |
H6 | Leere Überschrift |
H6 | Leere Überschrift |
H6 | Video Story |
H6 | Video Story Text-Duplikat |
H6 | Video Story Text-Duplikat |
H6 | Video Story Text-Duplikat |
H6 | Video Story Text-Duplikat |
H6 | Video Story Text-Duplikat |
(Nice to have)